Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 1600 to 1649 of 3228 in total
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    \def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent adapter-related protein complex 2 beta 1 subunit (beta-adaptin) (plasma membrane adaptor ha2/ap2 adaptin beta subunit) (clathrin assembly protein complex 2 beta large chain) (ap105b). [source:swissprot;acc:p21851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 222.103\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 225.675\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01608\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1601\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphomannomutase 2 (ec 5.4.2.8) (pmm 2). [source:swissprot;acc:o15305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.268\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01602\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1602\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phosphomannomutase 1 (ec 5.4.2.8) (pmm 1) (pmmh-22). [source:swissprot;acc:q92871]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.334\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.914\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01599\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1603\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 216.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01595\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1604\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase clk2 (ec 2.7.1.-) (cdc-like kinase 2). [source:swissprot;acc:p49760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.984\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.614\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01593\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1605\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hepatocyte nuclear factor 3-alpha (hnf-3a) (forkhead box protein a1). [source:swissprot;acc:p55317]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.322\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01592\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1606\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apolipoprotein a-i binding protein; apoa-i binding protein. [source:refseq;acc:nm\_144772]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 207.916\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.662\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0159\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1607\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein kinase clk3 (ec 2.7.1.-) (cdc-like kinase 3). [source:swissprot;acc:p49761]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 214.982\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 211.622\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01588\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1608\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 208.106\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.867\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01581\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1609\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 208.113\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.876\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.0158\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1610\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 variant 2; 1 alpha,25-dihydroxyvitamin d3-inducible; enterocyte differentiation promoting factor; methyl methanesulfonate sensitive 2, s. cerevisiae, homolog of. [source:refseq;acc:nm\_003350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 208.122\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01579\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1611\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent p10-binding protein. [source:refseq;acc:nm\_024491]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 221.313\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01577\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1612\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent enthoprotin; epsin 4; clathrin interacting protein localized in the trans-golgi region. [source:refseq;acc:nm\_014666]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 221.426\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 224.902\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0157\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1613\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hiv-1 tat interactive protein 2, 30kda; tat-interacting protein (30kd); hiv-1 tat interactive protein 2, 30 kda; hiv-1 tat interactive protein 2, 30 kd. [source:refseq;acc:nm\_006410]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 182.378\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 185.241\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1614\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hepatocyte nuclear factor 3-beta (hnf-3b) (forkhead box protein a2). [source:swissprot;acc:q9y261]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 217.233\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 213.897\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0156\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1615\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna polymerase epsilon subunit b (ec 2.7.7.7) (dna polymerase ii subunit b). [source:swissprot;acc:p56282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 246.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 242.596\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1616\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent n-acetylglutamate synthase. [source:refseq;acc:nm\_153006]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 223.179\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 226.611\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01538\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1617\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine hydroxymethyltransferase, cytosolic (ec 2.1.2.1) (serine methylase) (glycine hydroxymethyltransferase) (shmt). [source:swissprot;acc:p34896]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 221.045\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.699\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01537\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1618\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription elongation factor a protein 2 (transcription elongation factor s-ii protein 2) (testis-specific s-ii) (transcription elongation factor tfiis.l). [source:swissprot;acc:q15560]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 227.768\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 231.246\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01527\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1619\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription elongation factor a protein 1 (transcription elongation factor s-ii protein 1) (transcription elongation factor tfiis.o). [source:swissprot;acc:p23193]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1620\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription initiation factor iib (general transcription factor tfiib) (s300-ii). [source:swissprot;acc:q00403]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 228.611\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 225.185\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01521\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1621\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent thyroid receptor interacting protein 3 (trip-3) (fragment). [source:swissprot;acc:q15649]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1622\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nhp2-like protein 1 (high mobility group-like nuclear protein 2 homolog 1) ([u4/u6.u5] tri-snrnp 15.5 kda protein) (otk27). [source:swissprot;acc:p55769]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1623\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nuclear fragile x mental retardation protein interacting protein 1; nuclear fragile x mental retardation intercating protein 1; nuclear fragile x mental retardation protein-interacting protein 1. [source:refseq;acc:nm\_012345]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1624\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rrp5 protein homolog (programmed cell death protein 11). [source:swissprot;acc:q14690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 230.643\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 227.194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01518\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1625\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 217.446\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.2\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01515\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1626\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent z-protein (protein cgi-119) (s1r protein). [source:swissprot;acc:q9hc24]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1627\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pp1201 protein. [source:refseq;acc:nm\_022152]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1628\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lifeguard; kiaa0950 protein. [source:refseq;acc:nm\_012306]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1629\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sterol regulatory element binding protein-2 (srebp-2) (sterol regulatory element-binding transcription factor 2). [source:swissprot;acc:q12772]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1630\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sterol regulatory element binding protein-1 (srebp-1) (sterol regulatory element-binding transcription factor 1). [source:swissprot;acc:p36956]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1631\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.789\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.533\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01511\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1632\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitotic checkpoint protein bub3. [source:swissprot;acc:o43684]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 221.934\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.658\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01498\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1633\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein 207. [source:swissprot;acc:o43670]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1634\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent malonyl-coa decarboxylase, mitochondrial precursor (ec 4.1.1.9) (mcd). [source:swissprot;acc:o95822]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 215.772\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.596\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01494\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1635\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent itchy homolog e3 ubiquitin protein ligase; atrophin-1 interacting protein 4; itchy (mouse homolog) e3 ubiquitin protein ligase; nfe2-associated polypeptide 1; ubiquitin protein ligase itch. [source:refseq;acc:nm\_031483]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1636\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent beclin 1 (coiled-coil myosin-like bcl2-interacting protein) (protein gt197). [source:swissprot;acc:q14457]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 202.358\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 199.408\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01479\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1637\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 26s protease regulatory subunit 8 (proteasome subunit p45) (thyroid hormone receptor interacting protein 1) (trip1) (msug1 protein) (tat-binding protein homolog 10) (tbp10) (p45/sug). [source:swissprot;acc:p47210]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1638\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent serine hydroxymethyltransferase, mitochondrial precursor (ec 2.1.2.1) (serine methylase) (glycine hydroxymethyltransferase) (shmt). [source:swissprot;acc:p34897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 220.686\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.481\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01474\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1639\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent yl-1 protein (transcription factor-like 1). [source:swissprot;acc:q15906]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 194.516\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 197.364\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01464\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1640\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyacylglutathione hydrolase (ec 3.1.2.6) (glyoxalase ii) (glx ii). [source:swissprot;acc:q16775]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1641\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proteasome subunit beta type 4 precursor (ec 3.4.25.1) (proteasome beta chain) (macropain beta chain) (multicatalytic endopeptidase complex beta chain) (proteasome chain 3) (hsn3) (hsbpros26). [source:swissprot;acc:p28070]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 218.167\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.034\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01457\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1642\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent m-phase inducer phosphatase 2 (ec 3.1.3.48) (dual specificity phosphatase cdc25b). [source:swissprot;acc:p30305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 260.269\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 256.531\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1643\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myofibrillogenesis regulator 1; trans-activated by hepatitis c virus core protein 2; likely ortholog of mouse brain protein 17. [source:refseq;acc:nm\_022572]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 194.476\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 197.305\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01455\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1644\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent secreted modular calcium-binding protein 1. [source:refseq;acc:nm\_022137]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 217.256\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 214.149\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.01451\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1645\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent prefoldin subunit 1. [source:swissprot;acc:o60925]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1646\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent secreted modular calcium-binding protein 2; smooth muscle associated protein 2. [source:refseq;acc:nm\_022138]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1647\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent choline dehydrogenase. [source:refseq;acc:nm\_018397]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1648\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyindole o-methyltransferase (ec 2.1.1.4) (hiomt) (acetylserotonin o-methyltransferase) (asmt). [source:swissprot;acc:p46597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.745\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 222.928\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01448\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1649\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neurotrypsin precursor (ec 3.4.21.-) (motopsin) (leydin). [source:swissprot;acc:p56730]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 219.062\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.942\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.01445\vspace{3pt}}\\\hline nd{longtable}
    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/